Researcher Profile

Keywords Cloud

KRIBB Co-Working

Results 1-20 of 92 (Search time: 0.006 seconds).

No. Year Title Type
92 2024

2024Article

CYB5R3 functions as a tumor suppressor by inducing ER stress-mediated apoptosis in lung cancer cells via the PERK-ATF4 and IRE1α-JNK pathwaysExperimental and Molecular Medicine, vol. 56, no. 1, pp. 235-249Joo-Young Im; S J Kim; Jong Lyul Park; Tae Hee Han; Woo-Il Kim; Inhyub Kim; Bomin Ko; So-Young Chun; Mi-Jung KangBo Kyung Kim, et al.
Article
91 2023

2023Patent

DDIAS 억제제 및 사멸 수용체 리간드를 포함하는 암의 예방 또는 치료용 조성물KR10-2017-0115249 (2017.09.08) / 10-2532779 (2023.05.10)원미선; 임주영반현승김보경
Patent
90 2023

2023Article

TNF-α secreted from macrophages increases the expression of prometastatic integrin αV in gastric cancerInternational Journal of Molecular Sciences, vol. 24, no. 1, pp. 376-376Mi Aie Hwang; Misun Won; Joo-Young ImMi-Jung Kang; D H Kweon; Bo Kyung Kim
Article
89 2023

2023Research Project

바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2023.01.01 ~ 2023.12.31
Research Project
88 2023

2023Article

DDIAS, DNA damage-induced apoptosis suppressor, is a potential therapeutic target in cancerExperimental and Molecular Medicine, vol. 55, no. 5, pp. 879-885Joo-Young ImMi-Jung KangBo Kyung Kim; Mi Sun Won
Article
87 2022

2022Patent

SYT11 억제제를 유효성분으로 포함하는 위암 치료용 조성물KR10-2019-0129281 (2019.10.17) / 10-2377702-0000 (2022.03.18)염영일; 원미선; 반현승김보경박경찬
Patent
86 2022

2022Article

Synaptotagmin 11 scaffolds MKK7-JNK signaling process to promote stem-like molecular subtype gastric cancer oncogenesisJournal of Experimental & Clinical Cancer Research, vol. 41, pp. 212-212Bo Kyung Kim; Da Mi Kim; Hyunkyung Park; Seon-Kyu Kim; Mi Aie Hwang; Jungwoon LeeMi-Jung Kang; Jae Eun Byun; Joo-Young ImMinho Kang, et al.
Article
85 2022

2022Research Project

암대사를 조절하는 MDH1/2 이중 저해 항암물질 개발 = Development of anti-cancer drug MDH1/2 dual inhibitor controling cancer metabolism연구책임자 : 원미선 / 사업기간 : 2022.01.01 ~ 2023.06.30
Research Project
84 2022

2022Article

DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor-resistant lung cancer therapyExperimental and Molecular Medicine, vol. 54, no. 8, pp. 1236-1249Haejeong Heo; Jong-Hwan Kim; Hyun Jung Lim; Jeong Hwan Kim; M Kim; J Koh; Joo-Young ImBo Kyung Kim; Mi Sun Won; Ji Hwan Park, et al.
Article
83 2022

2022Research Project

바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2022.01.01 ~ 2022.12.31
Research Project
82 2021

2021Patent

cyb5R3 유전자 또는 단백질을 유효성분으로 포함하는 암 예방 및 치료용 약학적 조성물US15/087,563 (2016.03.31) / 10,973,884 (2021.04.13)김동욱; 원미선; 김보경; 이영주; 오경진임주영반현승
Patent
81 2021

2021Patent

cyb5R3 유전자 또는 단백질을 유효성분으로 포함하는 암 예방 및 치료용 약학적 조성물CN201480064255.2 (2016.05.25) / ZL201480064255.2 (2021.02.26)김동욱; 원미선; 이영주; 반현승김보경
Patent
80 2021

2021Article

DGG-100629 inhibits lung cancer growth by suppressing the NFATc1/DDIAS/STAT3 pathwayExperimental and Molecular Medicine, vol. 53, no. 4, pp. 643-653Joo-Young ImBo Kyung Kim; S H Yoon; B C Cho; Y M Baek; Mi-Jung Kang; N Kim; Y D Gong; Mi Sun Won
Article
79 2021

2021Article

VGLL1 phosphorylation and activation promotes gastric cancer malignancy via TGF-β/ERK/RSK2 signalingBiochimica et Biophysica Acta-Molecular Cell Research, vol. 1868, pp. 118892-118892Joo-Young Im; Da Mi Kim; Hyunkyung Park; Mi-Jung Kang; Da Yoon Kijm; K Y Chang; Bo Kyung Kim; Mi Sun Won
Article
78 2021

2021Article

Targeting HSF1 as a therapeutic strategy for multiple mechanisms of EGFR inhibitor resistance in EGFR mutant non-small-cell lung cancer = 활성 EGFR 발현 비소세포 폐암의 EGFR 표적항암제에 대한 다중 내성 치료표적으로의 HSF1Cancers, vol. 13, no. 12, pp. 2987-2987Sangah Lee; JiYae Jung; Yu-Jin LeeSeon-Kyu KimJung Ae KimBo Kyung KimKyung Chan Park; Byoung-Mog Kwon; Dong Cho Han
Article
77 2021

2021Research Project

바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2021.01.01 ~ 2021.12.31
Research Project
76 2021

2021Research Project

종양미세환경 조절을 통한 위암세포 증식 및 전이 조절 기전 연구연구책임자 : 김보경 / 사업기간 : 2021.03.01 ~ 2022.02.28
Research Project
75 2021

2021Research Project

암대사를 조절하는 MDH1/2 이중 저해 항암물질 개발 = Development of anti-cancer drug MDH1/2 dual inhibitor controling cancer metabolism연구책임자 : 원미선 / 사업기간 : 2021.01.01 ~ 2021.12.31
Research Project
74 2020

2020Patent

장형 위암의 예후 진단 마커KR10-2018-0125768 (2018.10.22) / 10-2136747-0000 (2020.07.16)원미선; 김보경김선규박경찬
Patent
73 2020

2020Patent

말릭산 탈수소효소 저해 활성을 갖는 신규 화합물 및 이를 유효성분으로 포함하는 암 예방 또는 치료용 약학적 조성물KR10-2018-0027397 (2018.03.08) / 10-2082504 (2020.02.21)원미선; 반현승김보경
Patent
1 2 3 4 5